Ignite Creation Date:
2025-12-24 @ 4:01 PM
Ignite Modification Date:
2026-01-03 @ 10:42 PM
Study NCT ID:
NCT04601766
Status:
COMPLETED
Last Update Posted:
2021-06-30
First Post:
2020-10-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase I, Two-phase, Crossover Study to Evaluate the Safety, Tolerability and Pharmacokinetics of APL-1501 ER Tablets
Sponsor:
Asieris Pharmaceuticals (AUS) Pty Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
YHGT-PN-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None